Literature DB >> 4800208

Primary lymphosarcoma of the lung.

G M Rees.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4800208      PMCID: PMC470053          DOI: 10.1136/thx.28.4.429

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  PULMONARY MALIGNANT LYMPHOMAS AND PSEUDOLYMPHOMAS: CLASSIFICATION, THERAPY, AND PROGNOSIS.

Authors:  S L SALTZSTEIN
Journal:  Cancer       Date:  1963-07       Impact factor: 6.860

2.  Primary lymphosarcoma of the lung.

Authors:  M G BARON; W M WHITEHOUSE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-02

3.  PRIMARY LYMPHOMA OF THE LUNG: AN APPRAISAL OF ITS NATURAL HISTORY AND A COMPARISON WITH OTHER LOCALIZED LYMPHOMAS.

Authors:  A N PAPAIOANNOU; W L WATSON
Journal:  J Thorac Cardiovasc Surg       Date:  1965-03       Impact factor: 5.209

4.  Primary lymphosarcoma of the lung.

Authors:  C W HAVARD; J B NICHOLS; A G STANSFELD
Journal:  Thorax       Date:  1962-09       Impact factor: 9.139

Review 5.  Primary lymphosarcoma of the lung.

Authors:  B A Jenkins; R Salm
Journal:  Br J Dis Chest       Date:  1971-10
  5 in total
  5 in total

1.  Primary lymphosarcoma of the lung.

Authors:  R L Hurt; W P Kennedy
Journal:  Thorax       Date:  1974-03       Impact factor: 9.139

2.  Primary lymphosarcoma of lung associated with hypertrophic pulmonary osteoarthropathy.

Authors:  G F Benfield
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

3.  Primary lymphosarcoma of the lung with unusual features.

Authors:  A J Veliath; K K Khanna; B S Subhas; M R Ramakrishnan; A L Aurora
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

4.  Respiratory distress as primary symptom of relapse in a patient with non-Hodgkin lymphoma.

Authors:  A D Ho; M Kleckow; E Rix; W Hunstein
Journal:  Blut       Date:  1985-10

5.  Primary malignant lymphoma of lung.

Authors:  A Sakula
Journal:  Postgrad Med J       Date:  1979-01       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.